Kasula Nagaraja1, Kummara Madhusudana Rao2, Duddekunta Hemalatha1, Sunmi Zo2,3, Sung Soo Han2,3, K S V Krishna Rao1. 1. Polymer Biomaterial Design and Synthesis Laboratory, Department of Chemistry, Yogi Vemana University, Kadapa, Andhra Pradesh 516005, India. 2. School of Chemical Engineering, Yeungnam University, 280 Daehak-Ro, Gyeongsan, Gyeongbuk 38541, South of Korea. 3. Research Institute of Cell Culture, Yeungnam University, 280 Daehak-Ro, Gyeongsan, Gyeongbuk 38541, South Korea.
Abstract
Natural Strychnos potatorum L. (SPL) polysaccharide-based dual-responsive semi-IPN-type (SPL-DMA) hydrogels have been fabricated using dimethylaminoethyl methacrylate by simple free radical polymerization. Furthermore, a facial and eco-friendly method has been developed for the green synthesis of silver nanoparticles on SPL-DMA hydrogel templates (SPL-DMA-Ag) using an aqueous leaf extract of Carissa spinarum (as a bioreducing agent). SPL-DMA and SPL-DMA-Ag were characterized using Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), thermogravimetry analysis (TGA), differential scanning calorimetry (DSC), scanning electron microscopy (SEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), and evaluated network parameters. 5-Fluorouracil and doxorubicin were successfully encapsulated, and in vitro drug release studies were performed at pH values of 1.2 and 7.4 and at 25 and 37 °C. To understand the drug release mechanism of SPL-DMA hydrogels, various kinetic parameters were calculated. Biocompatibility and anticancer activities of SPL-DMA hydrogels were proved by an antioxidant activity study and in vitro cell viability studies against HeLa and 3T3-L1 cell lines. SPL-DMA-Ag hydrogels were used for antibacterial application.
Natural Strychnos potatorum L. (SPL) polysaccharide-based dual-responsive semi-IPN-type (SPL-DMA) hydrogels have been fabricated using dimethylaminoethyl methacrylate by simple free radical polymerization. Furthermore, a facial and eco-friendly method has been developed for the green synthesis of silver nanoparticles on SPL-DMA hydrogel templates (SPL-DMA-Ag) using an aqueous leaf extract of Carissa spinarum (as a bioreducing agent). SPL-DMA and SPL-DMA-Ag were characterized using Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), thermogravimetry analysis (TGA), differential scanning calorimetry (DSC), scanning electron microscopy (SEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), and evaluated network parameters. 5-Fluorouracil and doxorubicin were successfully encapsulated, and in vitro drug release studies were performed at pH values of 1.2 and 7.4 and at 25 and 37 °C. To understand the drug release mechanism of SPL-DMA hydrogels, various kinetic parameters were calculated. Biocompatibility and anticancer activities of SPL-DMA hydrogels were proved by an antioxidant activity study and in vitro cell viability studies against HeLa and 3T3-L1 cell lines. SPL-DMA-Ag hydrogels were used for antibacterial application.
In
recent years, polysaccharide-based biomaterials have been extensively
used in the fields of pharmaceuticals,[1−3] food,[4,5] and
environment[6] due to their biocompatibility,
biodegradability, easy availability, and cost-effectiveness. The best
source of polysaccharides is plant materials/living organisms, which
contain a structurally diverse class of biomacromolecules; these are
obtained by either whole biosynthesis or chemical synthesis.[7] Biomacromolecules possess a broad range of physiochemical
properties, which are highly useful for food, medical, and biological
applications.[1−6] Hence, the use of polysaccharide-based biomaterials is gaining huge
importance over fully synthetic materials.To improve the bioavailability
of chemotherapeutic agents, various
types of carriers such as micelles, liposomes, micro/nanoparticles,
beads, films, and hydrogels have been developed to overcome their
inherent drawbacks.[8] Compared to other
types of carriers, hydrogels have been widely investigated owing to
their easy fabrication, high stability, and significant encapsulation
efficiency.[9] Hydrogels are water-swellable
3D polymeric networks that exhibit a significant stimuli-responsive
behavior in an external environment, i.e., pH, temperature, ionic
environment, light, and electric and magnetic fields. In addition,
hydrogel properties such as functionality, swelling, porosity, mechanical
strength, opacity, shape, and flexibility can be altered based on
the requirement.[9] These versatile properties
of hydrogels enable them to be used extensively for biomedical applications,
especially in the development of artificial organs and in wound healing
and controlled drug/gene delivery. Nowadays, synthetic polymer hydrogels
are fully replacing polysaccharide-based hydrogels because they are
biocompatible and biodegradable, which are the prime criteria to choose
hydrogels as anticancer drug delivery devices, which in turn eliminate
surgical operations after the loaded drug is exhausted in the implanted
material.[10−14]In the present work, we hypothesize the use of Strychnos
potatorumL. (SPL) seed polysaccharide
for fabrication of a stimuli-responsive semi-IPN-type hydrogel, which
is responsive to tumor microenvironment for chemotherapeutic drug
delivery and templates for green synthesis of silver nanoparticles
for antimicrobial (wound healing) applications. SPL is a moderate
tree that belongs to the family of Loganiaceae and
is mostly found in Sri Lanka, Burma, and the southern and central
parts of India.[15−18] All parts of this tree have a significant medical value; hence,
it is widely used as a medicine in the Indian traditional system (Ayurveda)
for the treatment of diseases such as eye and urinary tract infections.[19−21] However, the seeds of SPL polysaccharide consist of a 1:1.7 ratio
of a mixture of galactomannan and galactan moieties; the chemical
structure of this polysaccharide is β-(1 → 4)-linked
D-galctopyranose bearing side chains with mannopyranosyl.[15−18]The prime aim of this study is to fabricate new SPL polysaccharide-based
stimuli-responsive hydrogels and their silver nanocomposites. So far,
various types of hydrogel-based drug delivery devices using commercially
available natural polymers such as guar gum, gum ghatti, gum karaya,
xanthan gum, alginate, carboxymethyl cellulose, pectin, and chitosan
have been reported.[9] There have been no
reports on SPL polysaccharide-co-dimethylaminoethyl methacrylate (SPL-DMA)-based
semi-IPN hydrogels so far; in addition, Carissa spinarum aqueous leaf extract is used as a green reducing agent for the synthesis
of silver nanoparticles in the SPL-DMA semi-IPN hydrogel networks.
But to the best of our knowledge, this is the first report on fabrication
of hydrogels from SPL polysaccharide for in vitro drug release of chemotherapeutics, cancer cell viability studies,
antioxidant activity, and antimicrobial applications.
Experimental Section
Materials
S. potatorumL. seeds were purchased
from Sirigiri Venkappa
Ayurveda store, Nandyala, Andhra Pradesh, India. Dimethylaminoethyl
methacrylate (DMAEMA), acrylamide, N,N-methylene bisacrylamide (MBA), and ammonium persulphate (APS) were
purchased from Sigma-Aldrich Chemical Co. 5-Fluorouracil, silver nitrate,
sodium hydroxide, and hydrochloric acid were purchased from SD Fine
Chemicals, Mumbai, India. Doxorubicin hydrochloride (DOX) was received
from LC laboratories. All of the chemicals were used as received,
and double-distilled water (DDW) was used for all experiments.
Isolation of S. potatorumL. (SPL) Polysaccharide
The polysaccharide
was isolated from SPL seeds as per the procedure adopted by Matteo
Adinolfi et al.[15] Briefly, SPL seeds were
washed twice with double-distilled water, then crushed into small
pieces, and ground well into a fine powder with a mixer grinder. Next,
5 gm of the seed powder was taken in a 500 mL beaker, 250 mL of distilled
water was added, and the mixture was stirred overnight, followed by
centrifugation at 8000 rpm for 10 min. The supernatant solution was
filtered with Whatman cellulose acetate filters. The filtrate was
added to a 1:1 tris buffer saturated with phenol and chloroform. The
resulting emulsion was stirred for 1 h, followed by centrifugation
at 8000 rpm for 10 min. The aqueous layer was separated, then mixed
with equal volumes of chloroform, followed by centrifugation as per
the above conditions, and finally added to three-fold of ethanol to
obtain a white precipitate of polysaccharide. The precipitate was
stored in a refrigerator at 0 °C for further use. The polysaccharide
is characterized using Fourier transform infrared (FTIR), 1H NMR, and 13C NMR spectroscopies (Figure S1).
Fabrication of SPL-DMA
Semi-IPN Hydrogels
To fabricate SPL-DMA semi-IPN hydrogels,
a simple redox polymerization
technique was employed using ammonium persulphate (APS) as an initiator
and N,N-methylene bisacrylamide
(MBA) as a cross-linker. The polymerization reaction was carried out
in a 50 mL beaker, which consisted of 5 mL of DDW; to this beaker,
specific amounts of 2 wt % SPL, 1 wt % APS, and 2 wt % MBA aqueous
solutions were added and stirred to obtain a homogeneous solution,
which was then purged with N2 gas for 10 min. Finally,
DMAEMA was added and stirred thoroughly for 10 min and then for 180
min at room temperature (30 °C) to obtain a semitransparent hydrogel.
The formed SPL-DMA semi-IPN hydrogels were immersed in DDW water for
48 h, and the water was changed every 6 h to remove any unreacted
species. Finally, hydrogel discs were dried at 45 °C and stored
at room temperature for further use.
Green
Synthesis of Silver Nanocomposite Hydrogels
Preparation
of C. spinarum Aqueous Leaf Extract
(CSLE)
Fresh leaves of C. spinarum plant were collected from the premises
of Yogi Vemana University, Vemana Puram, Kadapa, Andhra Pradesh, India
(14.468552, 78.714183), in May 2019. The collected leaves were washed
thoroughly with running tap water and then DDW to remove any adhered
dust particles. Further, these leaves were air-dried for 1 week and
kept in a hot air oven for 48 h at 40 °C. The dried leaves were
ground into a fine powder. Then, 1 g of leaf powder was transferred
into a 250 mL beaker containing 100 mL of DDW, and the system was
continuously stirred at 100 °C. The aqueous leaf extract was
filtered using Whatman filter paper (No. 4), and a clear solution
obtained was collected and stored at 4 °C for further experiments.
The digital photographs of the SPL tree, SPL seeds, SPL seed powder,
and SPL-DMA hydrogels are shown in Figure S1.
Green Synthesis of SPL-DMA-Ag Nanocomposite
Hydrogels
In the first step, SPL-DMA semi-IPN hydrogel samples
were equilibrated with DDW by the transfer of accurately weighed 1
mg of the dried sample into a 50 mL beaker containing 25 mL of DDW.
The second step involves silver ionization of the SPL-DMA hydrogel
by transfer of the DDW equilibrated hydrogel into the 50 mL beaker
containing 25 mL of 5 mM AgNO3 aqueous solution. Finally,
the silver-ionized hydrogel is transferred into the 50 mL beaker containing
20 mL of C. spinarum aqueous CSLE,
and reduction of silver ions into silver nanoparticles begins to occur,
indicated by the change of the hydrogel color to dark brown. The reduction
process is allowed for 4 h to complete the reaction. The digital photographs
of C. spinarum leaves and SPL-DMA-Ag
hydrogel nanocomposite are shown in Figure S1.
Swelling Studies
Swelling profiles
of fabricated SPL-DMA semi-IPN hydrogels were determined by immersing
a preweighed hydrogel in DDW at room temperature (30 °C).[2] The swollen hydrogels were weighed at regular
intervals after blotting the surface-adhered liquid with tissue paper.
The swelling ratio of hydrogels was calculated using the following
relationshipwhere W0 is the
dried/initial weight of the hydrogel and W is the weight of the swollen hydrogel at time t.Equilibrium swelling at various pH values (1, 3,
5, 7, 9, and 11) and temperatures (25, 30, 35, and 40 °C) was
also determined to prove the dual-responsive behavior of the hydrogel.
The equilibrium swelling ratio was then calculated by the following
relationshipwhere We is the
weight of the swollen hydrogel at equilibrium time. All of the swelling
experiments were performed in triplicate, and the data points represent
the mean ± stranded deviation.
Encapsulation
Studies of 5-Fluorouracil
5-Fluorouracil (5-FU), an anticancer
drug, was loaded into SPL-DMA
semi-IPN hydrogels by a simple physical absorption method. 5-FU solubility
of 13 mg/mL deionized water, which increases with addition of sodium
salt (NaOH).[2] Dried hydrogels were transferred
into a known concentration of an aqueous sodium salt of 5-FU solution
and allowed to swell for 36 h at room temperature. Finally, incubated
gels were removed from the solution and dried at room temperature
for 24 h and then for 48 h at 45 °C. To evaluate the encapsulation
efficiency of 5-FU, 10 mg of drug-loaded SPL-DMA semi-IPN hydrogels
was placed in a phosphate buffer solution, pH 7.4, for about 48 h
and crushed well with an agate mortar. The solution was then filtered
to separate the polymeric gel and rinsed with buffer. In the case
of DOX encapsulation, the dried SPL-DMA hydrogel (about 200 mg) was
transferred to 25 mL (1 mg/mL) of DOX solution equilibrated for 24
h at room temperature to load the drug into the hydrogel. The drug-loaded
swollen hydrogel was washed rapidly with double-distilled water to
remove excess drug molecules on the surface. The 10 mg of dried drug-loaded
gel was placed in phosphate buffer solution (PBS), and complete DOX
entrapment was allowed for 24 h. The solution was filtered, and the
removed polymeric gel was washed twice with buffer solution.The filtrate was analyzed using a UV–visible spectrophotometer
(LAB INDIA, UV-3092, Mumbai, India) at a wavelength λmax of 269 nm for 5-FU and λmax of 490 nm for DOX.
The % 5-FU/DOX loading and % encapsulation efficiency of 5-FU/DOX
were calculated using the following relationship.
Drug Release Studies
5-FU and DOX
release studies were performed with a tablet dissolution tester (LAB
INDIA, DS-8000, India) at 37 °C with a speed of 100 rpm in pH
1.2 and 7.4 buffer solutions (GIT conditions). For all formulations,
100 mg of the drug-encapsulated SPL-DMA semi-IPN hydrogel was taken
in each basket, which was already filled with 500 mL of buffer. At
predetermined intervals, 2 mL of the sample was taken out and the
release of 5-FU was analyzed by adsorption at a wavelength λmax of 269 nm for 5-FU and λmax of 490 nm
for DOX using the UV–visible spectrophotometer (LAB INDIA,
UV-3092, Mumbai, India). The amounts of 5-FU and DOX were calculated
using the drug standard calibration curve. After each sampling, 2
mL of fresh buffer was added to maintain a constant volume of the
solution. Each experiment was carried out in triplicate, and the final
results were calculated as an average with mean ± standard deviation.
Antioxidant Assay
SPL-DMA hydrogel
antioxidant activity tests were carried out using the 2,2-diphenyl-1-picrylhydrazyl
(DPPH) scavenging assay. In the DPPH scavenging assay, a SPL-DMA hydrogel
sample of 10 mg was placed in a test tube with a methanolic solution
of DPPH radical, and a DPPH solution without the hydrogel sample and
with ascorbic acid was taken as a reference in another test tube.
The reaction solution was kept in the dark, and the absorbance was
measured at λmax 517 nm using ultraviolet–visible
spectroscopy. The experiments were carried out in triplicate.
Cell
Viability Studies
Human cervix
adenocarcinoma cell line (HeLa) and mouse embryo fibroblast (3T3-L1)
cells were obtained from American Type Culture Collection (ATCC) and
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
with high glucose supplemented with 10% fetal bovine serum (FBS) along
with 1% 100 U/mL penicillin/streptomycin (Gibco, Invitrogen Ltd.).
Cells were maintained in a humidified incubator at 37 °C under
a 5% CO2 atmosphere.The cell viability of samples was analyzed
using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)
assay and HeLa and 3T3-L1. The cells (HeLa and 3T3-L1) were seeded
at a density of 10 000 cells/cm2 and were allowed
to attach in a culture medium (100 μL) for 24 h. The culture
medium was discarded from the well plates and incubated with different
concentrations of pure SPL-DMA hydrogel, 5-FU-loaded hydrogel, DOX-loaded
hydrogel, pure 5-FU, and pure DOX. Then, 100 μL of MTT solution
(0.5 mg/mL in DDW) was added and incubated for 1 h at 37 °C.
Finally, the MTT reagent was removed, and then 100 μL of DMSO
was added to solubilize the formed formazan crystals. The solution
was swirled homogeneously for about 20 min with a shaker. The optical
density was measured using a microplate reader at 570 nm (Bio-T Instruments,
Inc.). All experiments conducted were analyzed in triplicate, and
data were presented as near-standard deviation.
Antimicrobial Studies
The antimicrobial
activity of SPL-DMA semi-IPN hydrogel silver nanocomposites (SPL-DMA-Ag)
was investigated using the disc diffusion method. Antimicrobial studies
of SPL-DMA-Ag samples were performed on bacteria, i.e., Escherichia coli (ATCC 25922), Pseudomonas
aeruginosa (ATCC 27853), Staphylococcus
aureus (ATCC 25923), and Klebsiella
pneumonia (ATCC 700603). All of the required reagents
and agar media were sterilized at 121 °C and 6.8 kg pressure
for 30 min in an autoclave. Bacterial strains were procured from the
Department of Microbiology, Yogi Vemana University, India, and used
in the present study. Mueller Hinton agar (M173) plates were inoculated
with Gram-positive and Gram-negative bacterial suspensions. After
solidification of the media solution in Petri dishes, 0.1 mL of an
18 h old bacterial suspension culture was spread using a sterile spreader
on the solid surface. The 5 mg/5 mL sample aqueous solutions were
prepared and 30 μL was added to each plate; then, the plates
were inoculated for 20 h at 37 °C. The zone formed around the
well is measured in millimeters and compared with a standard (tetracycline).
Characterization
To identify the
chemical structure and functional groups of isolated SPL polysaccharide,
SPL-DMA semi-IPN hydrogel, 5-FU/DOX-loaded SPL-DMA semi-IPN hydrogel,
5-FU, DOX, CSLE, and CSLE-reduced SPL-DMA-Ag semi-IPN hydrogel, they
were analyzed using Fourier transform infrared (FTIR, Perkin Elmer
Spectrum 2 model) spectroscopy. In addition, SPL polysaccharide was
analyzed using a Bruker NMR spectrometer at a probe temperature of
298 K and operated using a 400 MHz instrument. The green synthesis
of silver from silver ions was monitored using the UV–visible
spectrometer (LAB INDIA, UV-3092, Mumbai, India) at about λmax of 425. To understand the uniform distribution and presence
of 5-FU/DOX in the SPL-DMA semi-IPN hydrogel network and the structure
of the green synthesized silver nanoparticles from CSLE, samples are
analyzed using an X-ray diffractometer (Rigaku, Minflex 600, Japan).
X-ray diffractograms were recorded at 2θ values from 10 to 80°
under Cu Kα radiation (λ = 1.5406). Also, differential
scanning calorimetry (DSC) (TA Instruments, SDT Q600, U.K.) was used
to better understand the uniform distribution and presence of 5-FU/DOX
throughout the hydrogel network. The DSC and TGA thermograms were
recorded under a N2 atmosphere in the range of 0–600
°C with a heating rate of 10 °C/min. Scanning electron microscopy
(SEM) images of SPL-DMA, drug-loaded SPL-DMA, and SPL-DMA-Ag semi-IPN
hydrogels were taken using a JEOL, JSM-IT500 InTouchScope. Samples
were sputtered with gold (thickness of ∼10 nm) and placed on
a copper stub, and SEM images were scanned with an accelerating voltage
of 15 kV. Also, energy-dispersive X-ray (EDX) spectroscopy of SPL-DMA-Ag
was measured at 5 kV. Transmission electron microscopy (TEM) images
of SPL-DMA-Ag were analyzed using an FEI Tecnai G2 F20
with acceleration voltages in the 100–120 kV range. Dynamic
light scattering (DLS) was performed for the size distribution of
silver nanoparticles present in the SPL-DMA-Ag hydrogel.
Results and Discussion
1H and 13C NMR Spectroscopies
of SPL Polysaccharide
The 1H NMR and 13C NMR spectra of pure isolated polysaccharide Strychnos
potatorum L. are presented in Figure S2. From the spectrum (Figure S2A), a broad peak was observed at δH 4.7 for solvent
(D2O), and another anomeric signal at δH 4.5 was observed for the glycosidic bond in addition, the anomeric
proton H2– H6 signals were observed at
around δH 4.07, 3.82, 3.70, and 3.62. The methine
peak of mannose polysaccharide and α- and β-anomeric protons
were designated as β-d-Man and α-d-Gal,
respectively. Mannose and galactopyranose of the polysaccharide were
observed at δH 3.40 and 2.32, respectively. From
the 1H NMR spectrum, the polysaccharide β-(1 →
4)-linked d-galctopyranose and β-mannopyranosyl, mannose,
and galactose units are responsible for anomeric hydrogens that appear
in different regions.[21,22]The 13C NMR
spectrum (Figure S2B) of the polysaccharide
showed a chemical shift value of the anomeric region at δC 104.29 ppm associated with C-1-β-d-mannose
and substituted α-d-galactose. The diagnostic peak
was observed at 77.97 ppm attributed to the C-4-linkage of the mannose
unit, and the resonance peak chemical shift values of β-d-mannose and galactose substituted peaks were attributed to
C-5 and C-6, respectively, at δC 71.56, 73.25, and
74.26 ppm. These regions suggested chemical shift values attributed
to broad-intensity peaks at δC 60.77, 65.49, and
69.86 ppm corresponding to galactose moiety units and at δC 40.84 ppm corresponding to the polysaccharide methine carbon
atom. These values are conclusive for the linear structure of (1 →
4)-β-d-galactomannan of S. potatorum L polysaccharide.[18,21,22]
FTIR Spectroscopy Analysis
FTIR spectra
(Figure ) of the SPL
polysaccharide, SPL-DMA semi-IPN hydrogel, 5-FU loaded SPL-DMA semi-IPN
hydrogel, 5-FU, DOX, CSLE, and CSLE-reduced SPL-DMA-Ag semi-IPN hydrogel
were obtained to investigate the functional groups of polysaccharide,
hydrogel formation, and the chemical stability of 5-FU/DOX in hydrogel
and to identify functional groups of CSLE involved in the bioreduction
of silver nanoparticles. In the spectrum of SPL polysaccharide (Figure A), the broad absorption
peak at 3411.26 cm–1 was attributed to −OH
stretching vibrations of the carbohydrate moiety, the peak at 1628.41
cm–1 to the carbonyl groups, and the peak at 1042.61
cm–1 to the C–O stretching vibrations in
the galctopyranose ring. The peak at 878 cm–1 is
attributed to the presence of α-d-glucose and those
at 740.61 and 528.38 cm–1 to the presence of the
polysaccharide glycoside linkage. In the spectrum of SPL-DMA semi-IPN
hydrogel (Figure b),
the broad absorption peak at 3411.06 cm–1 was attributed
to −OH stretching vibrations of the polysaccharide. The peaks
at 2924.38, and 2837.92 cm–1 are attributed to the
C–H stretching vibrations of the hydrogel and the −CH3 group of DMAEMA. Also, 1669.52 and 1450.12 cm–1 peaks are attributed to the primary amide and the N–H stretching
vibrations of DMAEMA and MBA. In the spectrum of 5-FU (Figure c), the peak at 1286 cm–1 is attributed to C–H bending vibration, peaks
at 1231.71 and 1145.30 cm–1 are attributed to C–F
bonds in 5-FU, and that at 809 cm–1 is attributed
to the C–H out-of-plane deformation in 5-FU. Figure d illustrates the spectrum
of 5-FU-loaded SPL-DMA semi-IPN hydrogel, which comprises all of the
significant peaks of both hydrogel and drug. In the spectrum of DOX
(Figure e), peaks
at 3449 and 1625 cm–1 are attributed to −OH
and −NH groups, respectively; peaks at 1576 and 1614 cm–1 are attributed to the aromatic double bond and primary
amine of DOX, respectively, and the peak at 1210 cm–1 is attributed to the C–O–C asymmetric stretching vibrations
of DOX. Figure f illustrates
the spectrum of DOX-loaded SPL-DMA semi-IPN hydrogel, which comprises
all of the significant peaks of both hydrogel and DOX. Hence, the
drug (5-FU or DOX) encapsulated in the SPL-DMA hydrogel is structurally
stable. In the spectrum shown in Figure g, major peaks are observed for CSLE at 3442.61,
2925.38, 2848.11, 1637.22, 1460.89, 1384.48, 1329.63, 1120.21, 1031.83,
and 580.24 cm–1 attributed to −OH stretching,
−C–H stretching of the methyl and amide groups, −C–H
symmetrical twisting, sulphonates, −C–O single bond,
−C–N stretching, and −C–S stretching vibrations.
These functional groups may be responsible for the bioreduction of
silver ions to silver nanoparticles (Figure h). Based on the FTIR results, the plausible
schematic diagram of the hydrogel structure is presented in Figure .
Figure 1
FTIR spectra of S. potatorum polysaccharide
(a), pure SPL-DMA hydrogel (b), pure 5-FU (c), 5-FU-loaded hydrogel
(d), pure DOX (e), DOX-loaded hydrogel (f), the aqueous leaf extract
of C. spinarum (g), and SPL-DMA hydrogel
silver nanocomposites (h).
Figure 2
Plausible
schematic diagram of SPL-DMA hydrogel fabrication and
its applications.
FTIR spectra of S. potatorum polysaccharide
(a), pure SPL-DMA hydrogel (b), pure 5-FU (c), 5-FU-loaded hydrogel
(d), pure DOX (e), DOX-loaded hydrogel (f), the aqueous leaf extract
of C. spinarum (g), and SPL-DMA hydrogel
silver nanocomposites (h).Plausible
schematic diagram of SPL-DMA hydrogel fabrication and
its applications.
UV–Vis
Spectrophotometry Analysis
UV–visible spectroscopy
is one of the simple and sensitive
techniques used to monitor metal nanoparticle synthesis. Silver nanoparticles
were synthesized by mixing known concentrations of AgNO3 and CSLE aqueous solutions to yield a dark brown solution within
4 h. To determine the bioreduction capacity of the CSLE, absorption
spectra of CSLE and CSLE-Ag were obtained, which are presented in Figure S3. The spectrum of CSLE-Ag showed a maximum
peak at the wavelength of around 430 nm, and no other specific peaks
were identified between 300 and 600 nm, which results in the formation
of silver nanoparticles without aggregation (silver clusters) by bioreduction
of CSLE from silver ions, which facilitates the quantum mechanical
phenomenon known as surface plasmon resonance. The same strategy was
applied for the green synthesis of silver nanoparticles in the SPL-DMA
hydrogel networks (as a nanoreactor), and the same characteristic
strong peaks with a bathochromic shift were observed, which is responsible
for the highly swelling nature of the hydrogel network. Here, semi-IPN
hydrogels acted as templates for the synthesis of silver nanoparticles,
due to the presence of nitrogen atoms of amide groups present in DMAEMA/MBA
and oxygen atoms of hydroxyl/carboxyl functional groups present in
the SPL polysaccharide. Hence, we believe that the present methodology
(green) helps us to fabricate silver nanoparticle-embedded hydrogel
networks, where silver nanoparticles are stabilized by the SPL polysaccharide
with bioreduction by CSLE.
X-ray Diffraction (XRD)
Analysis
XRD patterns of SPL polysaccharide, SPL-DMA semi-IPN
hydrogel, 5-FU-loaded
SPL-DMA semi-IPN hydrogel, DOX-loaded SPL-DMA semi-IPN hydrogel, 5-FU,
DOX, and SPL-DMA-Ag nanocomposites are depicted in Figure . The XRD patterns in Figure A,B have no significant
sharp peaks, indicating the amorphous nature of the SPL polysaccharide
and SPL-DMA semi-IPN hydrogel. However, the XRD spectrum of pure 5-FU
(Figure C) exhibits
characteristic peaks observed at 2θ values of 25, 28, and 33°
indicating the crystalline nature. The XRD spectrum of pure DOX (Figure D) exhibited peaks
at 2θ = 18.30, 23.24, 26.12, 31.40, 35.25, and 41.19°,
indicating the crystalline nature. In Figure E, the 5-FU-loaded SPL-DMA hydrogel exhibits
low-intensity characteristic peaks observed at 2θ values of
19, 25, 28, and 30°. In Figure F, the DOX-loaded SPL-DMA hydrogel exhibits low-intensity
characteristic peaks observed at 2θ values of 15.15, 17.85,
19.32, 22.14, and 24.18°. Hence, XRD patterns suggest that the
dispersion of 5-FU and DOX in the SPL-DMA-5-FU hydrogel network is
at the molecular level. The existence of Ag nanoparticles in the SPL-DMA
hydrogel network was investigated through XRD peaks in Figure G observed at 2θ values
of 27.64, 32.17, 38.32, 44.23, 64.23, and 77.46° for the planes
001, 111, 200, 220, and 311, respectively.[23,24]
Figure 3
XRD
spectra of S. potatorum polysaccharide
(A), pure SPL-DMA hydrogel (B), pure 5-FU (C), pure DOX (D), 5-FU-loaded
hydrogel (E), DOX-loaded hydrogel (F), and SPL-DMA hydrogel silver
nanocomposites (G).
XRD
spectra of S. potatorum polysaccharide
(A), pure SPL-DMA hydrogel (B), pure 5-FU (C), pure DOX (D), 5-FU-loaded
hydrogel (E), DOX-loaded hydrogel (F), and SPL-DMA hydrogel silver
nanocomposites (G).
Differential
Scanning Calorimetry (DSC) and
Thermogravimetry Analysis (TGA)
The thermal stability of
SPL polysaccharide, SPL-DMA hydrogel, 5-FU, DOX, 5-FU-loaded hydrogel,
and DOX-loaded hydrogel was characterized using DSC, and the curves
are shown in Figure I. The pure polysaccharide (SPL) (Figure Ia) exhibits a broad endothermic peak at
69.43 °C, which might be due to bound and unbounded moisture
evaporation or loss of water molecules from the polysaccharide unit.
For the pure SPL-DMA hydrogel (Figure Ib), endothermic peaks were observed at 93.62, 248.57,
and 359.94 °C due to the loss of absorbed moisture (water molecules)
and decomposition of amide and carbonyl groups in polysaccharide units,
respectively. 5-FU (Figure Ic) exhibits an endothermic peak at around 289.08 °C
and another peak was observed at 343.21 °C, which indicates polymorphism
and the melting point. DOX (Figure Id) exhibits endothermic peaks at 57.19 and 249.67
°C corresponding to its decomposition. The DOX-loaded hydrogels
(Figure If) show endothermic
peaks at around 83.59, 256.69, and 342.75 °C due to the loss
of moisture content in the hydrogel network, carbonyl functional groups,
and decomposition of polymer chain units, respectively. The 5-FU-loaded
SPL-DMA hydrogel (Figure Ig) exhibited an endothermic peak at 83.59 °C due to
the evaporation of moisture from the polymer backbone. Endothermic
peaks were observed at 252.70 and 296.15 °C due to polymer transition
and the loss of amide functional groups, respectively. The drugs DOX
and 5-FU do not exhibit their original significant peaks in the drug-loaded
hydrogel network. These results suggest that the drug may have a strong
association and molecular-level distribution throughout the hydrogel
network. The thermal degradation properties of SPL polysaccharide,
pure SPL-DMA hydrogel, 5-FU-loaded hydrogel, DOX-loaded hydrogel,
5-FU, and DOX were investigated using TGA, and the thermograms are
shown in Figure II.
For the SPL polysaccharide (Figure IIa), a weight loss of 13.34% was observed in the region
between 84.99 and 64.30 °C, which is due to the loss of absorbed
water molecules. As seen in Figure IIb, the pure SPL-DMA hydrogel showed two steps of
weight loss approximately; in the first step, we observed a 12.96%
weight loss in the region between 137.23 and 272.94 °C due to
dehydration of water molecules from the surface in the hydrogel network.
In the second step, weight loss was of 16.72% was observed in the
region between 353 and 416.29 °C, due to the decomposition of
amide functional groups and polysaccharide side-chain units. As seen
in Figure IIc, the
pure 5-FU drug shows two steps of weight loss: in the first step,
a 12.11% weight loss was found in the region of 133.47–225.33
°C due to the loss of amide chain, and in the second step, we
observed a weight loss of 8.17% in the region of 401.59–473.54
°C due to the loss of mass and degradation of the 5-FU compound.
As seen in Figure IId, the 5-FU composite SPL-DMA hydrogel weight loss was observed
in two steps: the first-step weight loss was observed at 16.96% in
the region of 150.81–306.64 °C due to polymer attributes
in the bound and unbound water molecules and hydroxyl groups. The
second-step weight loss was observed at 20.12% in the region of 371.41–452.79
°C. In Figure IIe, a weight loss of 5.3% was observed for pure DOX in the region
of 156.46–214.20 °C due to degradation of the molecular
mass of the DOX compound. As seen in Figure IIf, the DOX composite SPL-DMA hydrogel showed
a two-step weight loss: in the first step, we observed a weight loss
of 9.68% in the region of 122.86–249.82 °C, and in the
second step, we observed a weight loss of around 19.59% in the region
of 272.94–357.58 °C due to a loss of nitrogen-containing
functional groups and decomposition of polysaccharide chain units.
We observed high thermal stability for pure polysaccharide and SPL-DMA
pure gel and the drug-loaded hydrogel network.
Figure 4
DSC thermograms of (I)
SPL-DMA hydrogel (a), pure polysaccharide
(b), pure SPL-DMA gel (c), pure 5-FU (d), pure DOX (e), 5-FU-loaded
gel (f), and DOX-loaded gel and (II) TGA curves of SPL-DMA hydrogel
(a), pure polysaccharide, (b) pure SPL-DMA gel, (c) pure 5-FU, (d)
5-FU-loaded gel, (e) DOX-loaded gel, and (f) pure DOX.
DSC thermograms of (I)
SPL-DMA hydrogel (a), pure polysaccharide
(b), pure SPL-DMA gel (c), pure 5-FU (d), pure DOX (e), 5-FU-loaded
gel (f), and DOX-loaded gel and (II) TGA curves of SPL-DMA hydrogel
(a), pure polysaccharide, (b) pure SPL-DMA gel, (c) pure 5-FU, (d)
5-FU-loaded gel, (e) DOX-loaded gel, and (f) pure DOX.
SEM, EDAX, TEM, and DLS Studies
Figure presents the SEM
images of the pristine SPL-DMA hydrogel (A), drug-loaded SPL-DMA gel
(B), SPL-DMA-Ag (C); EDAX spectra of SPL-DMA-Ag; TEM images of SPL-DMA-Ag
(E-H); and DLS spectra of silver nanoparticles (I). Due to the presence
of hydrophilic functionalities in the SPL-DMA hydrogel network, the
surface morphology appears smooth, while the drug-loaded hydrogel
exhibits a rough surface due to the surface-adhered crystallites of
the drug. Rough surface morphology was also observed for the SPL-DMA-Ag
composite hydrogel due to the formation of Ag particles not only inside
the network but also on the surface. The presence of Ag nanoparticles
is evidenced using EDAX, i.e., the appearance of a strong absorption
band at around 3.2 keV. TEM images show a group of Ag nanoparticles
and their sizes, i.e., 20 nm. The size of Ag nanoparticles is further
evidenced by DLS.
Figure 5
FE-SEM images of SPL-DMA hydrogels: (a) pure hydrogels
(b), drug-loaded
gel (c), and SPL-DMA-Ag hydrogel (d); the SPL-DMA-Ag EDAX spectrum;
and the TEM images of (e) the SAED pattern of SPL-DMA-Ag of (f) 2
nm, (g) 5 nm, and (h) 20 nm; and (i) DLS spectra of SPL-DMA-Ag.
FE-SEM images of SPL-DMA hydrogels: (a) pure hydrogels
(b), drug-loaded
gel (c), and SPL-DMA-Ag hydrogel (d); the SPL-DMA-Ag EDAX spectrum;
and the TEM images of (e) the SAED pattern of SPL-DMA-Ag of (f) 2
nm, (g) 5 nm, and (h) 20 nm; and (i) DLS spectra of SPL-DMA-Ag.
Swelling Studies and Hydrogel
Network Parameters
Swelling behavior is one of the essential
characteristics of hydrogels,[25] and it
mainly depends on the surrounding environment
such as pH, temperature, and electric and magnetic fields. In the
present study, SPL-DMA hydrogels are evaluated for swelling and deswelling
kinetics and percentage of equilibrium swelling ratio (%ESR) at 32
°C. Figure S4 A shows the swelling
kinetics; the hydrogels reached maximum swelling in 72 h, but maximum
deswelling was observed in 10 h (Figure b). Overall, the %ESR is high for SPL-DMA-3
(3168) and low for SPL-DMA-4 (1811). High swelling behavior may be
due to the presence of more PDMAEMA hydrophilic polymer chains in
the hydrogel network. Figure S4C,D shows
the %ESR of the hydrogels at various pH values (1–11) and temperatures
(25–40 °C); the %ESR is more at a lower pH and a higher
temperature. %ESR values of SPL-DMA hydrogels decrease in a low-to-high
pH region (Figure S4C). This may be due
to the presence of ionizable amino groups on the PDMAEMA polymer chains;
at low pH values (1–3), these amino groups undergo electrostatic
repulsion (protonation), and at high pH values (7–9), the hydrogels
shrink (deprotonation).[2,26] The results of the temperature
effect on %ESR are presented in Figure S4D. %ESR is increased on increasing the temperature from 25 to 40 °C.
However, swelling does not increase much up to 30 °C, but a significant
increase is observed at 40 °C.
Figure 7
Cell viability studies
of SPL-DMA hydrogels against different cell
lines, HeLa and 3T3-L1 cell. Cell viability after 24 h of incubation
at various concentrations: untreated, 6.25, 12.5, 25, 50, and 100,
respectively. (a) HeLa cells and (b) 3T3-L1 cell line treatment with
hydrogels.
Based on the swelling data,
various diffusion parameters such as the polymer–solvent interaction
parameter (χ), molecular mass between cross-links (Mc), pore size (ξ), volume fraction (ϕ), and
effective cross-linking density (υe) were calculated
using the following equationsThe various network parameters
χ, Mc, ξ, ϕ, and υe are represented in Table . Changes in feed composition and the amount of cross-linking
agents have a significant impact on network characteristics. The overall
SPL-DMA hydrogel χ values range from 0.52 to 0.53, indicating
a satisfactory polymer–solvent interaction in the SPL-DMA hydrogel
network. On decreasing the cross-linker density and increasing the
DMAEMA concentration, both molecular mass between cross-links (Mc) and pore size (ξ) values increased.
The effective cross-linking density (υ) values range between 0.18 and 0.37, and the observed (υe) values drop as the Mc values
of the hydrogel network increase due to the presence of ionizable
tertiary amino groups.[26,27] We observe the presence of hydrophilic
functional groups −CONH and −OH in DMAEMA and protonation
of amino groups in an acidic environment, which forms quaternary ammonium
ions leading to network expansion.
Table 1
Feed Composition,
Percentage of Equilibrium
Swelling Ratio (%ESR), % Encapsulation Efficiency (%EE), and Network
Parameters of SPL-DMA Hydrogels
network
parameters
sample code
SPL (2%) (mL)
Am (g)
DMAEMA (mL)
MBA 2% (w/v) (mL)
APS 10% (w/v) (mL)
% ESR
% EE of 5-FU
% EE of DOX
χ
Mc
ξ
ø
υe
SPL-DMA-1
5
0.5
0.5
1.0
1.0
2656
56.25 ± 1.3
39.01 ± 1.2
0.5310
30220
44.53
30.98
0.2773
SPL-DMA-2
5
0.5
1.0
1.0
1.0
2142
71.06 ± 1.4
49.25 ± 1.1
0.5286
40212
44.33
29.19
0.2249
SPL-DMA-3
5
0.5
1.5
0.5
1.0
3168
77.18 ± 0.8
61.28 ± 0.8
0.5360
48583
45.71
20.56
0.1877
SPL-DMA-4
5
0.5
0.5
2.0
1.0
1811
44.82 ± 0.8
32.14 ± 0.7
0.5238
11474
29.19
37.08
0.3283
SPL-DMA-5
5
0.5
0.5
1.0
1.0
2268
72.28 ± 1.3
56.78 ± 0.5
0.5281
24798
35.19
30.08
0.2421
Encapsulation and In Vitro Drug Release Studies
The encapsulation efficiency data of the SPL-DMA hydrogel network
are shown in Table . 5-FU encapsulation efficiency of SPL-DMA hydrogels ranges between
44.82 ± 0.8 and 77.18 ± 0.8. DOX encapsulation efficiency
of SPL-DMA hydrogels ranges between 32.14 ± 0.7 and 61.28 ±
0.8. The maximum % encapsulation efficiency is observed for SPL-DMA-3.
The minimum % encapsulation efficiency was observed for SPL-DMA-4
formulation, these values were influenced by a high monomer concentration
and a lower amount of cross-linking agent. The cross-linker variation
decreases and swelling behavior increases, and all of the remaining
formulations follow the same trend.In vitro 5-FU delivery studies of SPL-DMA hydrogels were analyzed using a
tablet dissolution tester in simulated gastric (pH 1.2) and intestinal
(pH 7.4) environments at 37 °C. For SPL-DMA-3 formulation, 5-FU
release studies were performed at pH 7.4 and 25 and 37 °C. The
5-FU and DOX release profiles are shown in Figure , and the drug release kinetics is plotted
against the percentage of cumulative release versus time. These results
are evaluated and discussed with respect to the monomer and concentration,
as well as pH and temperature.
Figure 6
I. In vitro 5-FU release
of the SPL-DMA hydrogels.
(a) pH 1.2 and (b) pH 7.4 and (c) temperature effects at 25 and 37
°C. II. In vitro DOX release of the SPL-DMA
hydrogels. (a) pH 1.2 and (b) pH 7.4 and (c) temperature effects at
25 and 37 °C.
I. In vitro 5-FU release
of the SPL-DMA hydrogels.
(a) pH 1.2 and (b) pH 7.4 and (c) temperature effects at 25 and 37
°C. II. In vitro DOX release of the SPL-DMA
hydrogels. (a) pH 1.2 and (b) pH 7.4 and (c) temperature effects at
25 and 37 °C.The swelling kinetics
drug release behavior of the SPL-DMA hydrogel
controlled the drug release rate, and a higher amount of 5-FU was
released at pH 1.2 rather than at pH 7.4 as displayed in Figure . The 5-FU drug release
data of all formulations at pH 1.2 are shown in Figure A. The drug release rate of SPL-DMA -3 hydrogel
formulation was higher than those of other formulations. The drug
release behavior of all formulations of hydrogels was higher at pH
1.2 rather than at pH 7.4 because PDMAEMA concentration increased,
and controlled leaching of drug molecules exhibit a higher swelling
behavior at pH 1.2 as cationic amine groups of tertiary amine groups
undergo protonation of the acidic region and the alkaline medium undergoes
deprotonation of the hydrogel network. The alkaline medium of hydrogels
easily ionizable of amine groups shrinking nature of SPL-DMA hydrogel
network. The temperature-responsive behavior of SPL-DMA hydrogels
is well accepted in the pharmaceutical application of biomaterials.
The drug release and the mechanistic features of hydrogels change
in the environment, especially at high temperatures. In vitro drug release studies were performed in media at pH 7.4 and 25 and
37 °C, as shown in Figure . The temperature effect of PDMAEMA near to physiological
temperature lower critical solution temperature (LCST) around at 40–45
°C with respect to the environmental conditions. SPL-DMA-3 hydrogel
5-FU drug release temperature of 25 °C was observed at 2 h at
42.92%, 3 h at 62.48%, 86.80% at 5 h, 7 h at 94.40%, 12 h at 98.51%,
and 24 h at 99.03%, and 37 °C 5-FU drug release temperature was
observed at 2 h at 61.97%, 3 h at 65.73%, 5 h at 73.95%, 7 h at 78.62%,
12 h at 85.87%, 24 h at 90.87%, and 48 h at 96.18%. The drug release
of SPL-DMA-3 formulation was higher at 25 °C (gel in a swollen
state) than at 37 °C (in a collapsed state). The SPL-DMA-3 hydrogel
drug released 85.87% in 12 h, but the release rate increased up to
96.18% in 48 h with a controlled release, as the cationic amine groups
of tertiary amine groups undergo protonation easily at low temperature
but higher-temperature DMAEMA deprotonation of the amine groups of
the hydrogel is not easily ionizable due to the shrinking behavior
of the SPL-DMA hydrogel network. The same results are observed for
the DOX-loaded hydrogels (Figure ).
Figure 8
Antimicrobial
studies of SPL-DMA-Ag hydrogels against (a) K. pneumoniae, (b) S. aureus, (c) P. aeruginosa, and (d) E. coli and (e) zone inhibition of SPL-DMA-Ag hydrogels.
The in vitro drug release
of 5-FU and DOX from
SPL-DMA hydrogels was analyzed using different kinetic models, i.e.,
zero-order, first-order, Higuchi, Hixson–Crowell, and Korsmeyer–Peppas
models.where M and M∞ are the fractions
of the drug released at a time t, k is the rate constant, and n is the drug release
exponent.All kinetic parameters with a correlation coefficient
and rate
constant are represented in Table . The in vitro drug release kinetics
mechanism confirms that zero-order and Korsmeyer–Peppas models
are better fitted compared to other kinetic models. The first case
in the n < 0.5 polymer network follows Fickian
diffusion, the second case, i.e., 0.5 < n <
0.89, corresponds to non-Fickian diffusion and an anomalous mechanism,
and the third case, n = 1, completely follows non-Fickian
and supercase II drug release kinetics. The drug release data analyzed
to n values ranged between 0.35 and 0.50. n values indicate a completely Fickian diffusion transport
mechanism and in relaxation of a polymer hydrogel network plays a
vital role during the transport of drug molecules.[28,29]
Table 2
In vitro Drug Release
of Various Kinetic Models for 5-FU and DOX Release Studies
sample code
zero-order
first-order
Higuchi
Hixson–Crowell
Korsmeyer–Peppas
pH 1.2
pH 7.4
R
K0
R
K1
R
Kh
R
Khc
k
n
r
k
n
r
5-FU
SPL-DMA-1
0.986
0.750
0.898
0.038
0.898
0.016
0.941
0.032
1.74
0.38
0.9825
7.47
0.49
0.9744
SPL-DMA-2
0.998
0.759
0.900
0.077
0.900
0.033
0.922
0.034
4.55
0.50
0.9423
6.76
0.52
0.9638
SPL-DMA-3
0.973
0.756
0.869
0.041
0.998
0.032
0.917
0.033
4.85
0.48
0.9774
7.37
0.50
0.9712
SPL-DMA-4
0.994
0.567
0.899
0.029
0.899
0.012
0.948
0.025
6.80
0.48
0.9401
8.25
0.47
0.9822
SPL-DMA-5
0.995
0.361
0.897
0.041
0.985
0.030
0.952
0.027
6.70
0.35
0.9691
2.31
0.47
0.9882
DOX
SPL-DMA-1
0.986
0.750
0.898
0.038
0.898
0.016
0.941
0.032
1.74
0.38
0.9825
7.47
0.49
0.9744
SPL-DMA-2
0.998
0.759
0.900
0.077
0.900
0.033
0.922
0.034
4.55
0.50
0.9423
6.76
0.52
0.9638
SPL-DMA-3
0.973
0.756
0.869
0.041
0.998
0.032
0.917
0.033
4.85
0.48
0.9774
7.37
0.50
0.9712
SPL-DMA-4
0.994
0.567
0.899
0.029
0.899
0.012
0.948
0.025
6.80
0.48
0.9401
8.25
0.47
0.9822
SPL-DMA-5
0.995
0.361
0.897
0.041
0.985
0.030
0.952
0.027
6.70
0.35
0.9691
2.31
0.47
0.9882
Antioxidant Activity Assay
The DPPH
activity experiment demonstrates that SPL-DMA hydrogels have a discernible
capability of radical scavenging, with the trend expected to vary
with dose. The ability of the polymer to scavenge radicals is slightly
lower than that of ascorbic acid. The reduction of DPPH is used to
calculate the antioxidant activity of the SPL-DMA hydrogel. After
2 h, the DPPH radical scavenging activity was 60.73 ± 0.9%. Thongchai
and co-workers have shown that natural polysaccharides have antioxidant
properties.[30]
Cell
Viability Assay of the SPL-DMA Hydrogel
Figure displays the dose-dependent cytotoxicity of pure SPL-DMA
hydrogel, 5-FU-loaded SPL-DMA hydrogel, DOX-loaded SPL-DMA hydrogel,
pure 5-FU, and pure DOX against HeLa and 3T3-L1 cells.Cell viability studies
of SPL-DMA hydrogels against different cell
lines, HeLa and 3T3-L1 cell. Cell viability after 24 h of incubation
at various concentrations: untreated, 6.25, 12.5, 25, 50, and 100,
respectively. (a) HeLa cells and (b) 3T3-L1 cell line treatment with
hydrogels.The IC50 value was
determined using the linear regression
equationHere, Y = 50, and M and C values were derived from the viability
graph.The IC50 values for pure ST hydrogel treated
with HeLa
and MT3L1 cells are 95.42 and 172. 66 μg/mL, respectively. The
results of the anticancer activity of 5-FU on HeLa show high anticancer
activity with an IC50 value of 14.88 μg/mL. The 5-FU-loaded
hydrogel also shows good anticancer activity against HeLa cells with
an IC50 value of 23.40 μg/mL. The results clearly
demonstrated the anticancer activity of the 5-FU-loaded hydrogel with
a 2.5-fold and two-fold reduction in anticancer activity as compared
to pure 5-FU. It is expected that 5-FU delayed the release from hydrogel
networks. In the case of DOX, the anticancer activity of HeLa is high
with an IC50 value of 10.09 μg/mL. DOX-loaded hydrogels
treated with HeLa cells show an IC50 value of 29.85 μg/mL.
As expected, DOX-loaded hydrogels show high anticancer activity toward
HeLa cells. However, the 5-FU- and DOX-loaded hydrogels are cytotoxic
against 3T3-L1 cells with IC50 values of 84.21 μg/mL
and 106.97 μg/mL, respectively, whereas pure hydrogel is not
cytotoxic against 3T3-L1 cells (IC50 = 172.66 ug/mL). Overall,
the 5-FU- and DOX-loaded hydrogels show high anticancer activity toward
HeLa cells.[31,32]
Antimicrobial
Activity Assay
Due
to the stimuli-responsive behavior and importance of multifunctional
hydrogels, they have been widely used in wound healing and tissue
engineering applications.[33,34] In the present study,
SPL-DMA-Ag hydrogel nanocomposites developed by a green method by
reduction of silver ions into silver nanoparticles using an aqueous
leaf extract of C. spinarum showed
excellent antibacterial activity toward Gram-positive and Gram-negative
bacteria, as shown in Figure . These nanocomposites showed
significant zone inhibition against K. pneumonia ranging between 12 ± 0.9 and 14 ± 1.4 mm, Figure b shows S. aureus zone inhibition ranging between 12 ± 0.9 and 18 ± 1.2
mm, Figure c shows P. aeruginosa zone inhibition ranging between 10
± 1.5 and 14 ± 1.3 mm, and Figure d shows E. coli zone inhibition ranging between 16 ± 0.3 and 18 ± 1.1
mm. Based on the above results, silver nanoparticles have a high surface-to-volume
ratio, chemical stability, and controlled nanosize, which have a great
impact on antimicrobial properties.[35] The
positively charged silver ions are crucial for microbial activity
through the electrostatic repulsion between positively charged silver
ions and the negatively charged cell membrane of microorganisms.[36] The antibacterial mechanism of silver nanoparticles
is mainly due to alteration of membrane permeability, modification
of intracellular ATP levels and respiration, uncontrolled cellular
transport, loss of ATP, and DNA replication. Silver nanoparticles
also result in free radical generation and a release of silver ions
that lead to cell death.[37] Also, the plates
(Figure a–d)
showed that the control ampicillin antibiotic drug’s significant
zone inhibition of K. pneumonia was
observed at 14 ± 0.4 mm, S. aureus at 22 ± 0.5 mm, and E. coli at
24 ± 1.3 mm, but P. aeruginosa did not show zone inhibition. From the study, the SPL-DMA-Ag hydrogel
was observed to have strong and almost equal antimicrobial activity
when compared with the standard drug “ampicillin”.Antimicrobial
studies of SPL-DMA-Ag hydrogels against (a) K. pneumoniae, (b) S. aureus, (c) P. aeruginosa, and (d) E. coli and (e) zone inhibition of SPL-DMA-Ag hydrogels.
Conclusions
To confirm our hypothesis,
we developed natural S. potatorum L.
polysaccharide-based duel-responsive
hydrogels with dimethylaminoethyl methacrylate by simple redox polymerization
at ambient temperature. Also, these hydrogels were used as templates
to fabricate silver nanocomposites using an aqueous leaf extract of C. spinarum (as a bioreducing agent). SPL-DMA hydrogels
and their silver nanocomposites were characterized using UV–visible
and FTIR spectroscopies, DSC, XRD, SEM, EDAX spectroscopy, TEM, and
DLS. The dual-responsive behavior of the SPL-DMA hydrogel higher pH-equilibrium
swelling in acidic regions and at low temperatures. Hydrogels exhibited
a significant drug encapsulation efficiency and in vitro drug release characteristics of 5-fluorouracil and doxorubicin with
stimuli-responsive behavior. Drug release data demonstrate that release
and drug transport mechanisms solely followed Fickian diffusion. MTT
assay shows that drug-loaded hydrogels show significant elimination
of HeLa and 3T3-L1 cancer cells and hydrogels are compatible with
cells. Another potential application of this study is the antimicrobial
activity toward four different strains, namely, E.
coli, K. pneumonia, Bacillus cereus, and S. aureus. The developed SPL-DMA hydrogels can load and deliver various other
chemotherapeutic agents, are used as templates for metal nanoparticles,
and have potential biomedical applications.
Authors: Swati Biswas; T Murugesan; Sanghamitra Sinha; Kuntal Maiti; Jiaur Rahaman Gayen; M Pal; B P Saha Journal: Fitoterapia Date: 2002-02 Impact factor: 2.882
Authors: Gaurav Tiwari; Ruchi Tiwari; Birendra Sriwastawa; L Bhati; S Pandey; P Pandey; Saurabh K Bannerjee Journal: Int J Pharm Investig Date: 2012-01